Citations (50)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Kimberley A. Jones, Peter G. Gibson, Janelle Yorke, Robert Niven, Amber Smith & Vanessa M. McDonald. (2021) Attack, flare-up, or exacerbation? The terminology preferences of patients with severe asthma. Journal of Asthma 58:2, pages 141-150.
Read now
Read now
Cibele Suzuki, Nilceia Lopes da Silva, Praveen Kumar, Purnima Pathak & Siew Hwa Ong. (2017) Cost-effectiveness of omalizumab add-on to standard-of-care therapy in patients with uncontrolled severe allergic asthma in a Brazilian healthcare setting. Journal of Medical Economics 20:8, pages 832-839.
Read now
Read now
Carolina Walker, Sumit Gupta, Vimal Raj, Salman Siddiqui & Christopher E Brightling. (2011) Imaging advances in asthma. Expert Opinion on Medical Diagnostics 5:5, pages 453-465.
Read now
Read now
Dennis Keith Ledford. (2009) Omalizumab: overview of pharmacology and efficacy in asthma. Expert Opinion on Biological Therapy 9:7, pages 933-943.
Read now
Read now
Bobby Quentin Lanier & Anjuli Nayak. (2008) Prevalence and Impact of Nighttime Symptoms in Adults and Children With Asthma: A Survey. Postgraduate Medicine 120:4, pages 58-66.
Read now
Read now
Gennaro D’Amato, Antonello Salzillo, Amedeo Piccolo, Maria D’Amato & Gennaro Liccardi. (2007) A review of anti-IgE monoclonal antibody (omalizumab) as add on therapy for severe allergic (IgE-mediated) asthma. Therapeutics and Clinical Risk Management 3:4, pages 613-619.
Read now
Read now
Bradley Chipps, Roland Buhl, Kai-Michael Beeh, Howard Fox, Karen Thomas & Colin Reisner. (2006) Improvement in quality of life with omalizumab in patients with severe allergic asthma. Current Medical Research and Opinion 22:11, pages 2201-2208.
Read now
Read now
S. Dewilde, F. Turk, M. Tambour & T. Sandström. (2006) The economic value of anti-IgE in severe persistent, IgE-mediated (allergic) asthma patients:adaptation of INNOVATE to Sweden. Current Medical Research and Opinion 22:9, pages 1765-1776.
Read now
Read now
Julie Von Behren, Richard Kreutzer & Alexandra Hernandez. (2002) Self-Reported Asthma Prevalence in Adults in California. Journal of Asthma 39:5, pages 429-440.
Read now
Read now
Stephen Holgate, Jean Bousquet, Sally Wenzel, Howard Fox, Jeen Liu & Jordi Castellsague. (2001) Efficacy of Omalizumab, an Anti-immunoglobulin E Antibody, in Patients with Allergic Asthma at High Risk of Serious Asthma-related Morbidity and Mortality. Current Medical Research and Opinion 17:4, pages 233-240.
Read now
Read now
Articles from other publishers (40)
Lingling Tang, Li Liu, Xianhong Sun, Po Hu, Hui Zhang, Bohan Wang, Xiaona Zhang, Jinjin Jiang, Xia Zhao & Xiaolu Shi. (2022) BMAL1/FOXA2-induced rhythmic fluctuations in IL-6 contribute to nocturnal asthma attacks. Frontiers in Immunology 13.
Crossref
Crossref
Ian Mitchell & Gaynor GoviasIan Mitchell & Gaynor Govias. 2021. Asthma Education. Asthma Education
335
368
.
Barbara L. Knox, Francois M. Luyet & Debra Esernio-Jenssen. (2019) Medical Neglect as a Contributor to Poorly Controlled Asthma in Childhood. Journal of Child & Adolescent Trauma 13:3, pages 327-334.
Crossref
Crossref
Zsuzsanna Csoma, Zsófia Gál, András Gézsi, Irén Herjavecz & Csaba Szalai. (2020) Prevalence and characterization of severe asthma in Hungary. Scientific Reports 10:1.
Crossref
Crossref
Melissa Kapoor, Will Storrar, Lara Balls, Thomas P Brown, Adel Mansur, Emma Hedley, Tom Jones, Claire Roberts, Beverly Shirkey, Susan Dutton, Ramon Luengo-Fernandez, Matthew Little, Ann Dewey, Sue Marshall, Carole Fogg, Keith Boughton, Najib Rahman, Ly-Mee Yu, Peter Bradding, Peter Howarth & Anoop J Chauhan. (2019) Nocturnal temperature-controlled laminar airflow device for adults with severe allergic asthma: the LASER RCT. Health Technology Assessment 23:29, pages 1-140.
Crossref
Crossref
Cristina de Oliveira Francisco & Azadeh Yadollahi. (2019) Thoracic fluid accumulation and asthma symptoms: A new contributor mechanism. Porto Biomedical Journal 4:6, pages e40.
Crossref
Crossref
Michael R. Edwards, Andrew I. Ritchie & Sebastian L. Johnston. 2019. Rhinovirus Infections. Rhinovirus Infections
137
168
.
Clementine Nordon, Lamiae Grimaldi-Bensouda, Celine Pribil, Gaelle Nachbaur, Billy Amzal, Gabriel Thabut, Roger Marthan, Michel Aubier, M. Aubier, B. Crestani, C. Taillé, M.C. Dombret, M. Pretolani, P. Berger, A. Bourdin, I. Vachier, N. Molinari, P. Chanez, T. Similowski, A. Didier, F. De Blay, M. Humbert, G. Garcia, A. Magnan, B. Maitre, N. Roche, A. Tsicopoulos, C. Chenivesse, G. Deslée, C.H. Marquette & G. Devouassoux. (2018) Clinical and economic burden of severe asthma: A French cohort study. Respiratory Medicine 144, pages 42-49.
Crossref
Crossref
T. R. Tay & M. Hew. (2018) Comorbid “treatable traits” in difficult asthma: Current evidence and clinical evaluation. Allergy 73:7, pages 1369-1382.
Crossref
Crossref
Ian D. Pavord, Nicola Mathieson, Anna Scowcroft, Riccardo Pedersini, Gina Isherwood & David Price. (2017) The impact of poor asthma control among asthma patients treated with inhaled corticosteroids plus long-acting β2-agonists in the United Kingdom: a cross-sectional analysis. npj Primary Care Respiratory Medicine 27:1.
Crossref
Crossref
Rohit K. Katial, Greg W. Bensch, William W. Busse, Bradley E. Chipps, Joshua L. Denson, Anthony N. Gerber, Joshua S. Jacobs, Monica Kraft, Richard J. Martin, Parameswaran Nair & Michael E. Wechsler. (2017) Changing Paradigms in the Treatment of Severe Asthma: The Role of Biologic Therapies. The Journal of Allergy and Clinical Immunology: In Practice 5:2, pages S1-S14.
Crossref
Crossref
Andrew J. Ghio. (2016) Asthma as a disruption in iron homeostasis. BioMetals 29:5, pages 751-779.
Crossref
Crossref
Patrick W. Sullivan, Jonathan D. Campbell, Vahram H. Ghushchyan & Gary Globe. (2015) Outcomes before and after treatment escalation to Global Initiative for Asthma steps 4 and 5 in severe asthma. Annals of Allergy, Asthma & Immunology 114:6, pages 462-469.e6.
Crossref
Crossref
Reena Mehra. (2014) Understanding Nocturnal Asthma. The Plot Thickens. American Journal of Respiratory and Critical Care Medicine 190:3, pages 243-244.
Crossref
Crossref
Bradley E. Chipps, Robert S. Zeiger, Alejandro Dorenbaum, Larry Borish, Sally E. Wenzel, Dave P. Miller, Mary Lou Hayden, Eugene R. Bleecker, F. Estelle R. Simons, Stanley J. Szefler, Scott T. Weiss & Tmirah Haselkorn. (2012) Assessment of asthma control and asthma exacerbations in the epidemiology and natural history of asthma: outcomes and treatment regimens (TENOR) observational cohort. Current Respiratory Care Reports 1:4, pages 259-269.
Crossref
Crossref
Bradley E. Chipps, Robert S. Zeiger, Larry Borish, Sally E. Wenzel, Ashley Yegin, Mary Lou Hayden, Dave P. Miller, Eugene R. Bleecker, F. Estelle R. Simons, Stanley J. Szefler, Scott T. Weiss & Tmirah Haselkorn. (2012) Key findings and clinical implications from The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study. Journal of Allergy and Clinical Immunology 130:2, pages 332-342.e10.
Crossref
Crossref
Julie Morisset, Stanislaw Ptaszynski, Sawsan Al-Mot, Yvon Dubois & Céline Bergeron. (2012) A case of difficult-to-treat eosinophilic asthma controlled with clarithromycin. Annals of Allergy, Asthma & Immunology 109:1, pages 82-83.
Crossref
Crossref
Nancy E. Lange, Supinda Bunyavanich, Judy L. Silberg, Glorisa Canino, Bernard A. Rosner & Juan C. Celedón. (2011) Parental psychosocial stress and asthma morbidity in Puerto Rican twins. Journal of Allergy and Clinical Immunology 127:3, pages 734-740.e7.
Crossref
Crossref
Gustavo J. Rodrigo, Hugo Neffen & José A. Castro-Rodriguez. (2011) Efficacy and Safety of Subcutaneous Omalizumab vs Placebo as Add-on Therapy to Corticosteroids for Children and Adults With Asthma. Chest 139:1, pages 28-35.
Crossref
Crossref
Charlene M. Prazma, Kenneth M. Kral, Nadeem Gul, Steve W. Yancey & David A. Stempel. (2010) Controller medications and their effects on asthma exacerbations temporally associated with upper respiratory infections. Respiratory Medicine 104:6, pages 780-787.
Crossref
Crossref
Ohta Ken, Manabu Yamamoto, Norio Sato, Kimitoshi Ikeda & Terumasa Miyamoto. (2010) One Year Treatment with Omalizumab Is Effective and Well Tolerated in Japanese Patients with Moderate-to-Severe Persistent Asthma. Allergology International 59:2, pages 167-174.
Crossref
Crossref
Stephen Holgate, Roland Buhl, Jean Bousquet, Nicola Smith, Zoya Panahloo & Pablo Jimenez. (2009) The use of omalizumab in the treatment of severe allergic asthma: A clinical experience update. Respiratory Medicine 103:8, pages 1098-1113.
Crossref
Crossref
R. Niven, K.F. Chung, Z. Panahloo, M. Blogg & G. Ayre. (2008) Effectiveness of omalizumab in patients with inadequately controlled severe persistent allergic asthma: An open-label study. Respiratory Medicine 102:10, pages 1371-1378.
Crossref
Crossref
S. D. Sullivan & F. Turk. (2008) An evaluation of the cost-effectiveness of omalizumab for the treatment of severe allergic asthma. Allergy 63:6, pages 670-684.
Crossref
Crossref
Rachael L. DiSantostefano, Kourtney J. Davis, Steve Yancey & Courtney Crim. (2008) Ecologic analysis of asthma-related events and dispensing of inhaled corticosteroid- and salmeterol-containing products. Annals of Allergy, Asthma & Immunology 100:6, pages 558-565.
Crossref
Crossref
R. Brown, F. Turk, P. Dale & J. Bousquet. (2007) Cost-effectiveness of omalizumab in patients with severe persistent allergic asthma. Allergy 62:2.
Crossref
Crossref
Stephen T Holgate & Riccardo Polosa. (2006) The mechanisms, diagnosis, and management of severe asthma in adults. The Lancet 368:9537, pages 780-793.
Crossref
Crossref
Stephen P. Peters, Gary Ferguson, Yamo Deniz & Colin Reisner. (2006) Uncontrolled asthma: A review of the prevalence, disease burden and options for treatment. Respiratory Medicine 100:7, pages 1139-1151.
Crossref
Crossref
Nancy K. Ostrom. (2006) Women with asthma: a review of potential variables and preferred medical management. Annals of Allergy, Asthma & Immunology 96:5, pages 655-665.
Crossref
Crossref
Mark D. Eisner, Patricia P. Katz, Gretchen Lactao & Carlos Iribarren. (2005) Impact of depressive symptoms on adult asthma outcomes. Annals of Allergy, Asthma & Immunology 94:5, pages 566-574.
Crossref
Crossref
M. Humbert, R. Beasley, J. Ayres, R. Slavin, J. Hébert, J. Bousquet, K.-M. Beeh, S. Ramos, G. W. Canonica, S. Hedgecock, H. Fox, M. Blogg & K. Surrey. (2005) Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE. Allergy 60:3, pages 309-316.
Crossref
Crossref
J. Bousquet, P. Cabrera, N. Berkman, R. Buhl, S. Holgate, S. Wenzel, H. Fox, S. Hedgecock, M. Blogg & G. Della Cioppa. (2005) The effect of treatment with omalizumab, an anti-IgE antibody, on asthma exacerbations and emergency medical visits in patients with severe persistent asthma. Allergy 60:3, pages 302-308.
Crossref
Crossref
Chantal M. Dolan, Kyle E. Fraher, Eugene R. Bleecker, Larry Borish, Bradley Chipps, Mary Lou Hayden, Scott Weiss, Beiyao Zheng, Charles Johnson & Sally Wenzel. (2004) Design and baseline characteristics of The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study: a large cohort of patients with severe or difficult-to-treat asthma. Annals of Allergy, Asthma & Immunology 92:1, pages 32-39.
Crossref
Crossref
Mónika Kovács, Adrienne Stauder & Sándor Szedmák. (2003) Severity of allergic complaints. Journal of Psychosomatic Research 54:6, pages 549-557.
Crossref
Crossref
Ian Mitchell, Suzanne C. Tough, Lisa K. Semple, Francis H. Green & Patrick A. Hessel. (2002) Near-Fatal Asthma. Chest 121:5, pages 1407-1413.
Crossref
Crossref
Robert C. Strunk, Jean G. Ford & Virginia Taggart. (2002) Reducing disparities in asthma care: Priorities for research—National Heart, Lung, and Blood Institute Workshop Report. Journal of Allergy and Clinical Immunology 109:2, pages 229-237.
Crossref
Crossref
Marianna I Tovt-Korshynska, Mary Amanda Dew, Ivan V Chopey, Mikola Ya Spivak & Ivan S Lemko. (2001) Gender differences in psychological distress in adults with asthma. Journal of Psychosomatic Research 51:5, pages 629-637.
Crossref
Crossref
Richard Nicklas. (2001) THE FATALITY-PRONE ASTHMATIC. Immunology and Allergy Clinics of North America 21:3, pages 535-549.
Crossref
Crossref
Enrique Baca Baldomero, Jerónimo Sáiz Ruiz & Alberto Porras Chavarino. (2001) Detección de trastornos mentales por médicos no psiquiatras: utilidad del cuestionario PRIME-MD. Medicina Clínica 116:13, pages 504-509.
Crossref
Crossref
Nora Galil. (2000) Depression and asthma in children. Current Opinion in Pediatrics 12:4, pages 331-335.
Crossref
Crossref